I am not sure if you need to pay to view the whole article.
This article can be found in the following collections: Oncology (Haematological cancer)
Published Online: 21 August 2014
Safety and activity of ibrutinib plus rituxima... - CLL Support
Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukemia: a single-arm, phase 2 study
Written by
shazie
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
Ublituximab plus ibrutinib versus ibrutinib alone for patients with relapsed or refractory high-risk chronic lymphocytic leukaemia (GENUINE)
The Lancet, Feb22nd 2021. Jeff P Sharman, Mato et al
Patients with chronic lymphocytic leukaemia...
New research study reported in NEJM: Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia
Found this to be a good news article. I know some will say study was funded heavily by drug...
Health Canada approves Ibrutinib plus Rituximab for First Line Treatment of Patients with Chronic Lymphocytic Leukemia (CLL)
Good News for our untreated Canadian members!
This latest approval is based on...
Long-term safety of single-agent ibrutinib in patients with chronic lymphocytic leukemia in 3 pivotal studies
I have checked but apologies if this has been posted before.
Published online June 13, 2019.
Key...
Optimizing Treatment of Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
This is a short paper setting out the non trial option for patients needing treatment after a...
Related Posts
- Ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial treatment for younger patients with CLL
Guidelines for Diagnosis, Indications for Treatment, Response Assessment and Supportive Management of Chronic Lymphocytic Leukemia- Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: Update on The CLARITY Study
Results on triple combination (A+V+O) for high risk patients -with-chronic-lymphocytic-leukemia-or-small-lymphocytic-lymphoma-cll- Disease Flare During Temporary Interruption of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia ( CLL ) - Pseudo Richters
